Dexamethasone protects against membrane formation

Article

Dexamethasone protects against anterior membrane formation and doesn’t increase glaucoma risk.

Dexamethasone protects against anterior membrane formation and doesn’t increase glaucoma risk.

The retrospective case series, led by Dr Asimina Mataftsi, Clinical and Academic Department of Ophthalmology, London, UK, was comprised of 24 eyes of 18 infants who underwent cataract surgery with IOLs between January 1, 2007 and December 31, 2008.

Mean follow-up was 38 months and the median age at surgery was three months. Transient postoperative antihypertensive medication was used in four eyes, but there was no development of glaucoma during the follow-up period.

Of the eyes studied, 15 underwent a second procedure to clear the visual axis caused by posterior visual axis opacification. No eyes developed anterior membranes and Intracameral preservative-free dexamethasone doesn't seem to cause increased glaucoma risk.

To read the abstract please visit the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.